جست‌وجوی استاد و پژوهشگر

Steven G. Clarkeمشاهده پروفایل

استاد

• Biochemistry
• Systems Biology
• Biological Regulation
• +۸ مورد دیگر

Dr. Steven G. Clarke is a Distinguished Professor at UCLA Department of Chemistry & Biochemistry and director of research at the Molecular Biology Institute . His work bridges protein chemistry , methylation biology , and aging research through studies of spontaneous protein damage and its repair mechanisms. Education: BA in Chemistry and Zoology, Pomona College (magna cum laude, Phi Beta Kappa) PhD in Biochemistry and Molecular Biology, Harvard University (NSF Fellow) Postdoctoral Fellowship at UC Berkeley (Miller Fellow) Dr. Clarke's research focuses on protein isoaspartyl repair via PCMT1/PIMT enzymes , ribosomal protein methylation in Saccharomyces cerevisiae , and PRMT family characterization including PRMT7 and PRMT9. His lab combines biochemical assays , genetic models , and structural analysis to investigate aging mechanisms and disease implications. Recent publications highlight: COQ5 structure-function analysis in coenzyme Q biosynthesis PCMTD1 ubiquitin ligase interactions PRMT7 substrate specificity in histone H2B Protein isoaspartyl impacts on T cell function in lupus Novel PRMT inhibitors for cancer therapy Methionine addiction in osteosarcoma malignancy Major scientific awards: American Chemical Society Ralph F. Hirschmann Award in Peptide Chemistry NIH MERIT Award Ellison Medical Foundation Senior Scholar Award William C. Rose Award, ASBMB UCLA Distinguished Teaching Award (Eby Award winner) Current lab members include PhD candidates Eric Pang (UCSB) and Sining "Cindy" Wang (UCLA), while undergraduates Celeste Medina-Seymoure , Elizabeth Oroudjeva , Olivia Pacheco , and Jasmine Winter contribute to ongoing proteostasis studies. Collaborations with Profs. Jose Rodriguez and Catherine Clarke demonstrate interdisciplinary research approaches.

Harri Lähdesmäkiمشاهده پروفایل

دانشیار

• Probabilistic Machine Learning
• Deep Generative Models
• Artificial Intelligence
• +۴ مورد دیگر

Harri Lähdesmäki is an Associate Professor (tenured) at the Department of Computer Science, Aalto University, where he leads the Computational Systems Biology research group. His work focuses on probabilistic machine learning and deep generative models with applications in biomedicine and molecular biology. Key Research Interests: Probabilistic machine learning, deep generative models, computational biology, bioinformatics, longitudinal data modeling Contact: harri.lahdesmaki@aalto.fi | Konemiehentie 2, 02150 Espoo, Finland His recent publications highlight advancements in: Gaussian process priors for scalable deep generative models Single-cell analysis of immune repertoires in leukemia and diabetes Probabilistic deconvolution methods for RNA-seq data Epigenetic analysis using hidden Markov and mixed models Transformer-based survival prediction and missing data handling Harri’s work integrates mechanistic modeling with Bayesian inference, particularly applied to immunology, cancer biology, and early disease prediction.

Xiuwei Zhangمشاهده پروفایل

استادیار

• Computational Biology
• Bioinformatics
• Single-Cell Data Analysis
• +۵ مورد دیگر

Xiuwei Zhang is the J.Z. Liang Early-Career Assistant Professor in the School of Computational Science and Engineering (SCoSE) at Georgia Institute of Technology, part of the College of Computing. Her research focuses on computational biology and bioinformatics, particularly in developing machine learning methods for analyzing single-cell omics data, including multi-modal, temporal, and spatial data integration. She leads a lab that designs tools like scDART , scMoMaT , and scMultiSim , which address challenges in multi-omics integration, lineage reconstruction, and simulation. Before joining Georgia Tech, she held postdoctoral positions at UC Berkeley (Nir Yosef’s group), the European Bioinformatics Institute (EBI), and École Polytechnique Fédérale de Lausanne (EPFL). She earned her PhD in computer science from EPFL under Bernard Moret. Her Erdős number is 3, reflecting her collaborative work across computational fields. Her research spans four key areas: multi-batch/single-cell data integration, temporal analysis of cell differentiation, spatial-temporal omics dynamics, and simulation tools for benchmarking methods. She has received prestigious awards, including the NSF CAREER Award (2022) and NIH MIRA (2021). She actively participates in conferences (RECOMB, ISMB) and serves on editorial boards (Journal of Computational Biology). Her group’s recent work includes the scMultiSim simulator (2025), which generates multi-omics spatial data, and LinRace (2023), reconstructing cell lineage histories. She mentors over 15 students and collaborates internationally on projects like the InQuBATE Workshop on Single-Cell Transcriptomics.

Kenneth Hoehnمشاهده پروفایل

استادیار

• Computational Immunology
• Evolutionary Biology
• B Cell Biology
• +۵ مورد دیگر

Kenneth Hoehn is an Assistant Professor in the Department of Biomedical Data Science at the Geisel School of Medicine, Dartmouth College. As a computational immunologist with expertise in evolutionary biology, he develops computational evolutionary approaches to trace cellular lineages, particularly B cells, in contexts such as infection, vaccination, cancer, and autoimmune diseases. His research focuses on understanding adaptive immunity in conditions like COVID-19 Food allergies Myasthenia gravis through collaborations with experimental teams. Key projects include: Phylogenetic modeling of B cell responses Evolutionary signatures in immune repertoires Tracking B cell dissemination in autoimmune diseases Epigenetic regulation of memory B cells Recent publications highlight trends in single-cell immunology , phylogenetic inference , and computational tools for analyzing B cell dynamics. His lab at Dartmouth integrates evolutionary genetics with high-resolution immune profiling.

Aditi Dasمشاهده پروفایل

استاد

• Biochemistry and Chemical biology of Lipids
• Mechanism of Membrane proteins in Nanodiscs
• Enzymology of metalloproteins
• +۵ مورد دیگر

Aditi Das is a Full Professor in the School of Chemistry and Biochemistry at the Georgia Institute of Technology, College of Sciences. She leads the Das Laboratory, which focuses on the biochemistry and chemical biology of lipids, particularly studying cytochrome P450 enzymes and their role in lipid metabolism, endocannabinoid systems, and inflammatory pathways. Her educational background includes: B.Sc. in Chemistry from St. Stephen's College M.Sc. in Chemistry from Indian Institute of Technology, Kanpur (I.I.T) Ph.D. in Chemistry from Princeton University Postdoctoral research at Northwestern University (NSF-NSEC fellow) and Beckman Institute for Advanced Science and Technology, University of Illinois UC Professor Das's research interests center around understanding the physiological role of lipids in sustaining homeostasis and their implications in disease states such as neurodegenerative disorders, cancer, and cardiovascular diseases. Her laboratory specializes in: Enzymology of cytochrome P450s, particularly CYP2J2 epoxygenase Metabolism of ω-3 and ω-6 fatty acids and their derivatives Minor cannabinoid metabolism by cytochrome P450 enzymes Discovery of novel anti-inflammatory lipid metabolites and endocannabinoids Mechanistic studies of membrane proteins using nanodisc technology Her work bridges biochemistry, chemical biology, and pharmacology to uncover novel therapeutic targets related to lipid signaling pathways. Analysis of Professor Das's recent publications (2023-2025) reveals a strong focus on cannabinoid metabolism by cytochrome P450 enzymes, with particular emphasis on how these metabolic processes generate bioactive compounds that interact with the endocannabinoid system. Her research increasingly explores the therapeutic potential of omega-3 derived endocannabinoid epoxides in inflammatory and neurodegenerative conditions. The use of nanodisc technology for studying membrane proteins in near-native environments remains a consistent methodological thread throughout her work, enabling detailed mechanistic insights into enzyme function. Professor Das has received numerous prestigious awards recognizing her research excellence and teaching: 2024 NIH Outstanding Researcher Award (MIRA R35) for established investigators 2024 Vasser Woolley Faculty Fellowship 2023 Plenary Lecture at the International Society of the Study of Xenobiotics (ISSX) 2021 E.L.R. Stokstad Award 2019-2021 List of Teachers Ranked as Excellent 2019 Eicosanoid Research Foundation Young Investigator Award 2019 Zoetis Research Excellence Award 2019 Mary Swartz Rose Young Investigator Award 2015 National Scientist Development Award from the American Heart Association 2022 El Sohly Award from the American Chemical Society Professor Das actively mentors a diverse group of students and postdoctoral researchers, with several former lab members now holding faculty positions or working at prestigious institutions. Her laboratory has secured significant funding from NIH, NSF, and other sources to support research on lipid metabolism, cannabinoid pharmacology, and membrane protein biochemistry. Notable grants include an NIH R35 Outstanding Investigator Award (MIRA), an NIH R21 grant from NIDA, and multiple collaborative grants with other research groups. The Das Laboratory operates within the Petit Institute of Bioengineering and Biosciences (IBB) at Georgia Tech, utilizing state-of-the-art facilities for biochemical and biophysical studies. The lab specializes in nanodisc technology to study membrane proteins in near-native environments, with particular expertise in cytochrome P450 enzymes and their interactions with lipid substrates. Recent work has expanded into collaborative projects involving lipidomics, structural biology, and translational applications of lipid signaling research.

Bertram Müller-Myhsokمشاهده پروفایل

استاد پژوهشی

• Psychiatric Genetics
• Statistical Genetics
• Transcriptomics
• +۳ مورد دیگر

Bertram Müller-Myhsok is a Research Professor and Research Group Leader at the Max Planck Institute of Psychiatry in Munich, Germany. His research focuses on statistical genetics and transcriptomic data analysis in psychiatric disorders, particularly major depression, PTSD, schizophrenia, and their treatment responses. He integrates machine learning with genetic and clinical data to develop predictive models and stratified treatment approaches. Professional activities include leadership roles in the International Max Planck Research School for Translational Psychiatry and collaborations with institutions like the Institut du Cerveau (Paris) and Bernhard Nocht Institute (Hamburg). His work spans genetic epidemiology, psychiatric genomics, and precision medicine, with over 400 publications in high-impact journals. Key research areas include identifying genetic risk factors for mental disorders, developing polygenic scores, and leveraging omics data to uncover disease mechanisms. He leads projects like Psych-STRATA, a Horizon Europe-funded initiative advancing personalized psychiatry through pharmacogenomics.

Alicia Cheمشاهده پروفایل

استادیار

• Neuroscience
• Developmental Neuroscience
• Behavioral Neuroscience
• +۵ مورد دیگر

Alicia Che is an Assistant Professor of Psychiatry at Yale University School of Medicine and serves as Director of Graduate Admissions for the Interdepartmental Neuroscience Program. She joined the Yale Department of Psychiatry in 2021 after completing her postdoctoral fellowship with Dr. Natalia De Marco García at Weill Cornell Medical College and Dr. Gord Fishell at NYU. Her research is conducted through the Che Lab at Yale, where she investigates how early life experiences impact brain circuit assembly and mature function in models of psychiatric illness. Yale School of Medicine, Department of Psychiatry Interdepartmental Neuroscience Program Center for Brain & Mind Health Division of Molecular Psychiatry Wu Tsai Institute Yale Center for the Science of Cannabis and Cannabinoids Dr. Che earned her Ph.D. in Physiology and Neurobiology from the University of Connecticut in 2014, where she worked in the laboratory of Dr. Joseph LoTurco. She received her B.S. with triple majors in Biology, Physics, and Physical Chemistry from Pacific Lutheran University in Washington state in 2009. Her research focuses on understanding developmental trajectories following early life experiences to develop diagnostics and early interventions for psychiatric illnesses. Dr. Che's research examines how sensory inputs, social bonding, stress, and substance exposure impact brain development. She employs a multi-dimensional approach to assess transcriptional, circuit, neuronal activity, and behavioral changes across the entire developmental timeline. Her lab currently focuses on four specific areas: the role of oxytocin in social behavior development, circuit dysfunction in PTSD, early-life cannabinoid exposure effects, and the impact of early life stress on development and adulthood. She utilizes advanced techniques including mouse genetics, slice electrophysiology, and longitudinal in vivo 2-photon imaging on behaving animals. Her most recent publications demonstrate significant contributions to understanding neural circuit development, PTSD mechanisms, and the effects of early life experiences on brain function. Her work spans from molecular neuroscience to behavioral outcomes, with publications in top journals including Nature, Neuron, and Nature Communications. Her research has revealed important insights into how translaminar neuronal activity strengthens cortical columns, how oxytocin facilitates social touch development, and how PTSD affects brain transcriptomics. NARSAD Young Investigator Award (2020) K99/R00 Pathway to Independence Award from NINDS (2019) Dr. Che's work has significant implications for understanding and treating neurodevelopmental disorders, PTSD, and the consequences of early life experiences on mental health. She collaborates extensively with researchers across Yale and beyond, with frequent co-authorship with colleagues including Lin Lin, Alex Kwan, and Christopher Pittenger. Her research program bridges basic neuroscience with clinical applications, aiming to translate findings into potential interventions for psychiatric conditions.

• Epidemiology of Birth Defects
• Gene-Environment Interactions in Perinatal Health
• Nutrition and Reproductive Outcomes
• +۴ مورد دیگر

Gary M. Shaw is the Rosemarie Hess Professor and Professor (Research) at Stanford University , with courtesy appointments in the Department of Epidemiology and Population Health and Department of Obstetrics & Gynecology - Maternal Fetal Medicine . He serves as Co-PI of the March of Dimes Prematurity Research Center at Stanford and PI of the California Center for Finding Causes and Preventives of Birth Defects . His research focuses on the Epidemiology of birth defects Gene-environment interactions in perinatal outcomes Nutritional factors in reproductive health . He has developed machine learning approaches for precision parenteral nutrition and predictive models for preterm birth, while investigating persistent metabolomic signatures following hypertensive pregnancy disorders. Shaw's recent work explores Climate change impacts on reproductive health Maternal-fetal immune interactions Epigenetic mechanisms in perinatal disease with applications of multiomics to neonatal intensive care units. As a member of Bio-X and the Maternal & Child Health Research Institute , he contributes to translational research networks while serving as Associate Editor for Birth Defects Research and American Journal of Medical Genetics . He supervises Med Scholar Project student Richard Liang Doctoral co-advisor for Saskia Comess and Richard Liang Master's advisor for Lenae Joe while leading the Division of Neonatology as Associate Chair for Clinical Research (2012-2025). His laboratory work integrates Metabolomic profiling Proteomic analysis Computational modeling Machine learning for biomedical data to advance neonatal care through precision medicine approaches.

Kiran T. Thakurمشاهده پروفایل

دانشیار

• Neuroinfectious Diseases
• Neuroimmunology
• Global Health
• +۶ مورد دیگر

Dr. Kiran T. Thakur serves as the Herbert Irving Associate Professor of Neurology at Columbia University Irving Medical Center and practices as an inpatient neurologist at NewYork-Presbyterian/CUIMC. Her clinical expertise spans neuroinfectious diseases, neuroimmunology, emergency neurology, and global health, with active clinical and research engagements across eight countries in Africa, Southeast Asia, and the Caribbean. She holds leadership roles including Neurology Clerkship Director at Perdana University Graduate School of Medicine (Malaysia) and serves as a neurology consultant for the World Health Organization. Her educational background includes an MD from Tufts University School of Medicine (2008), internship at Johns Hopkins Hospital's Osler Medical Service, neurology residency at Harvard's Brigham & Women's Hospital (where she served as chief resident), and fellowship in neuroinfectious disease/neuroimmunology at Johns Hopkins Hospital. She is additionally pursuing a Master of Science in clinical trials at the London School of Tropical Medicine and Hygiene. Dr. Thakur's research program focuses on improving detection and management of neuroinfectious diseases in hospital settings, with particular emphasis on vulnerable populations including HIV-positive individuals and immigrants. Her work integrates clinical, translational, and implementation science approaches to address cerebral malaria, tuberculous meningitis, Zika-related complications, and SARS-CoV-2 neurological outcomes. Current projects investigate novel diagnostics for infectious meningoencephalitis, risk factors for neuroinvasive infections, and therapeutic strategies for viral encephalitis. Analysis of her 15 most recent publications reveals consistent focus on neuroinfectious disease epidemiology (particularly in resource-limited settings), diagnostic challenges in immunocompromised patients, and global health implementation strategies. Her work prominently features Zika virus complications, tuberculous meningitis management, and CNS infections in travelers, reflecting her dual expertise in tropical medicine and neuroimmunology. Scientific recognition includes: Lewis P. Rowland Teaching Award (Columbia University, 2016) CDC Nakona Citation Award (2014) Dr. Thakur directs the NIH NINDS K23-funded study on pathogen identification in neurological infections (2018-2023) and leads Columbia's post-doctoral neuroinfectious disease fellowship for physician-scientists from low/middle-income countries. Her research program receives support from the NIH, World Federation of Neurology, and American Academy of Neurology, with implementation studies conducted in collaboration with WHO, PAHO, and CDC. The Thakur Laboratory at Columbia's Neurological Institute coordinates international research networks across Malawi, Vietnam, Bangladesh, Uganda, and the Dominican Republic. Her team conducts clinical trials on antimicrobial dosing, develops diagnostic algorithms for resource-limited settings, and implements training programs to build neuroinfectious disease capacity in underserved regions, with current emphasis on SARS-CoV-2 neurological sequelae and tropical disease management.

• Ocular Genetics
• Gene Therapy
• Children's Vision Screening
• +۷ مورد دیگر

Alex V. Levin, M.D., M.H.Sc., serves as Professor in the Department of Ophthalmology at the University of Rochester School of Medicine and Dentistry, holding the Adeline Lutz - Steven S.T. Ching, M.D. Distinguished Professorship. He concurrently holds joint appointments in the Center for Visual Science and the Department of Pediatrics, Genetics. As Chief of the Flaum Eye Institute's Pediatric Ophthalmology and Ocular Genetics team and Chief of Clinical Genetics at URMC, he leads cross-functional teams comprising ophthalmologists, optometrists, pediatric specialists, geneticists, nurses, and genetic counselors. Medical Degree: Jefferson Medical College Residency: Pediatrics at Children's Hospital of Philadelphia Residency: Ophthalmology at Wills Eye Hospital Fellowship: Pediatric Ophthalmology and Strabismus at Toronto's Hospital for Sick Children Masters of Health Science in Bioethics: University of Toronto (2001) Dr. Levin's research spans ocular genetics and gene therapy, children's vision screening, pediatric glaucoma/cataract/uveitis, ocular manifestations of child abuse, and bioethics. His work integrates clinical expertise in pediatric anterior segment eye conditions with scientific investigation into genetic eye diseases. He maintains the only simultaneous US Board Certifications in pediatrics, ophthalmology, and child abuse pediatrics worldwide. Analysis of his 15 most recent publications reveals predominant focus on genetic eye disorders (73%), with significant emphasis on retinal hemorrhage patterns in trauma (13%) and pediatric glaucoma (7%). His research demonstrates consistent translational application from basic science to clinical practice, particularly in ocular genetics and abusive head trauma diagnostics. Resident Guardian Award (2022) Edward A. Jaeger and John B. Jeffers Citizenship Award (2020) Albert Marquis Lifetime Achievement Award (2018) Al Biglan Medal in Pediatric Ophthalmology (2014) Ray E. Helfer Society Award for Child Abuse Research (2011) With over 35 years of experience and hundreds of peer-reviewed publications, Dr. Levin has secured funding from the National Institutes of Health, Canadian Institute of Health, and private foundations. His research portfolio demonstrates exceptional continuity in pediatric ophthalmology and ocular genetics, with recent emphasis on deep learning applications for retinal hemorrhage analysis and international registry development for childhood glaucoma. He has established comprehensive vision screening programs for underserved urban populations and pioneered ethical frameworks for genetic testing in pediatric ophthalmology. Dr. Levin directs the Ocular Genetics Program at URMC, which provides multidisciplinary care through the Pediatric Ophthalmology and Ocular Genetics team. His laboratory investigations focus on nascent chromatin structure in fibrosis and protein modeling for inherited retinal diseases, with active collaborations across the Montalcino Aortic Consortium and Sturge-Weber Foundation research networks.

• Epigenetic Mechanisms
• Drug Discovery
• Target Discovery
• +۷ مورد دیگر

Professor Udo Oppermann serves as Professor of Molecular Biology and Director of Laboratory Sciences at the Institute of Musculoskeletal Sciences, Botnar Research Centre, University of Oxford. He is also Deputy Director of the Oxford Centre of Translational Myeloma Research and a fellow at St Catherine's College. His educational background includes a Diploma in Human Biology (1990) and PhD in Pharmacology and Toxicology (1994), both earned with distinctions from Philipps University Marburg. Prior academic appointments include Associate Professor at Karolinska Institutet (until 2004) and sabbatical work at Yale University. Research focuses on epigenetic mechanisms in disease through drug and target discovery using systems biology and single-cell approaches . Key disease targets include metabolic disorders, inflammatory conditions, and malignant diseases—particularly multiple myeloma and secondary bone cancers. His group pioneers chemical biology applications in primary tumor microenvironments. Current funding sources include Cancer Research UK, Innovate UK, EPSRC, Royal Society-Newton Fund, Bristol Myers Squibb, Bayer Healthcare, GlaxoSmithKline, Blood Cancer UK, and Leducq Foundation. Notable research trends show increasing emphasis on epigenetic regulation in immune cells (2020-2024), single-cell technologies for myeloma (2022-2024), and translational applications of chromatin modifiers (2016-2019). Recent work integrates metabolomics with epigenetic mechanisms in gynecological and hematological disorders. He supervises doctoral research including Singh K.'s 2024 thesis on sonodynamic therapy mechanisms. Leadership roles encompass directing Oxford's Molecular Laboratory Sciences division and co-leading translational myeloma research initiatives.

Maria Eriksdotterمشاهده پروفایل

استاد

• Alzheimer's Disease
• Geriatrics
• Dementia
• +۶ مورد دیگر

Professor Maria Eriksdotter is a leading academic in geriatrics and dementia research at the Karolinska Institutet , holding the Department of Neurobiology, Care Sciences and Society . She also serves as a Senior Consultant in Themes Inflammation and Ageing at Karolinska University Hospital Huddinge and previously as Dean of KI South (2019–2023). Her work spans translational research, clinical trials, and national registry development, with a focus on Alzheimer's disease, cholinergic therapies, and aging. Her research group pioneered NGF cell therapy for Alzheimer's patients, demonstrating safety and cognitive stabilization in clinical trials. She chairs the SveDem registry , tracking over 100,000 dementia patients to refine diagnostics and care. Studies from SveDem revealed mortality reduction with cholinesterase inhibitors and highlighted pandemic-era diagnostic delays. Recent publications analyze dementia subtypes , comorbidities , and precision medicine in neurodegeneration. Her work intersects neuroimaging , epidemiology , and public health policy , addressing ageism and improving geriatric care systems. Collaborations span Karolinska University Hospital , NSGene Inc , and international institutions.

Ancha Baranovaمشاهده پروفایل

استاد

• Bio-health/Health
• Biomedical Research
• Neuroscience
• +۶ مورد دیگر

Ancha Baranova is a Professor at George Mason University's School of Systems Biology, with dual affiliations in the Neuroscience Program as both Research and Instructional Faculty. She directs the MS in Biology program, Certificate in Personalized Medicine, and the Chronic Metabolic and Rare Diseases Systems Biology Initiative (ChroMe RaDSBIn). Education: DSci in Genetics (Institute of General Genetics, Russian Academy of Science, 2004), PhD in Molecular Biology/Virology (Lomonosov Moscow State University, 1998), MS in Biochemistry (Lomonosov Moscow State University, Russia, 1995) Her research spans transdisciplinary biomedical domains, focusing on: Identifying biomarkers for chronic diseases Anti-aging research (systemic inflammation, insulin resistance, organ fibrosis) Personalized medicine through longitudinal health monitoring Non-pharmacological homeostasis augmentation Molecular network analysis in cancer, liver diseases, and neurodegeneration Recent work leverages Mendelian randomization and multi-omics to explore causal relationships between gut microbiota, metabolic biomarkers, and conditions like Alzheimer's disease, depression, and psychiatric disorders. Scientific Awards: COS Publication Awards (2013, 2011) She has developed analytical frameworks for multidimensional datasets across 20+ years in academia and contributes to bioinformatics education through program leadership roles.

• Neuromuscular Medicine
• Neurophysiology
• Stress Biomarkers
• +۴ مورد دیگر

Kunal Desai, MD is an Assistant Professor of Neurology at Yale School of Medicine , serving as Director of Neuromuscular Medicine at Greenwich/Stamford and Interim Stroke Medical Director at Greenwich Hospital. His clinical and research work focuses on neuromuscular diseases and neurophysiology. Education: BS in Biology from Boston College (2007) MD from Creighton University School of Medicine (2012) Intern at Greenwich Hospital (2013) Neurology Residency & Chief Residency at Albert Einstein/Montefiore Medical Center (2016) Neuromuscular Fellowship at Albert Einstein/Montefiore Medical Center (2017) Dr. Desai specializes in neuromuscular medicine , treating conditions like ALS , myasthenia gravis , inflammatory myopathies , and peripheral neuropathies . He is certified by the American Board of Electrodiagnostic Medicine , with fluency in Hindi, Gujarati, and Marathi . His research explores non-pharmacological interventions for stress and burnout reduction among healthcare professionals, focusing on Heartfulness Meditation and gratitude practices through randomized controlled trials. Recent publications analyze Mindfulness-based wellbeing strategies and work engagement metrics in clinical settings. He emphasizes team-based patient care , advocating for regular communication between neurology specialists and primary care physicians to improve treatment outcomes.

• Matrix Biology
• Immunology
• Rheumatology
• +۵ مورد دیگر

Professor Kim Midwood serves as Professor of Matrix Biology and Kennedy Director of Graduate Studies at the University of Oxford's Kennedy Institute of Rheumatology, leading research on extracellular matrix dynamics in inflammatory diseases and cancer. Her academic foundation includes: BSc (Hons) in Biochemistry from the University of Edinburgh (1995) PhD in Pathology from the University of Edinburgh (1999), investigating extracellular matrix changes in arthritis Her research centers on matrix immunology, particularly tenascin-C's role in rheumatoid arthritis, tumor microenvironments, and fibrosis. She examines how tissue-specific matrix composition dictates immune cell behavior through toll-like receptor signaling and chemokine networks, revealing novel therapeutic targets for chronic inflammatory conditions. Publications from 2013-2025 demonstrate evolving focus from arthritis mechanisms to broader applications in cancer immunotherapy and regenerative medicine, consistently highlighting matrix molecules as central regulators of disease progression. Her accolades include: MRC New Investigators Award (2007) Arthritis Research UK Senior Fellowship (2012) She directs the Matrix Immunology research group (established 2004 at Imperial College London, relocated to Oxford in 2011) and founded biotech company Nascient Ltd (2012) to translate matrix-targeting discoveries into clinical therapies.